/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that Chief Executive Officer Dr. Ulf Jungnelius M.D. and Isofol s Board of.
/PRNewswire/ Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), ("Isofol" or the "Company"), announced today that the members of the nomination committee.
/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) ("Isofol"), will publish the company s results for the third quarter of 2022 on Friday,.
/PRNewswire/ Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL) today reported data from the AGENT study that formed the basis for its assessment that it.
/PRNewswire/ Isofol Medical AB (publ), (NASDAQ Stockholm: ISOFOL), announced today that the company s interim report for January-June 2022 is now available.